Fruquintinib CYP3A Inhibitor and Inducer Study

Clinical trial NCT04557397 · COMPLETED

Trial details

NCT number: NCT04557397
Sponsor: Hutchison Medipharma Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Drug Interaction

Start date: 2020-09-02
Primary completion: 2020-10-18
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.